SCHEMBL23394

SCHEMBL23394

CNc1nc2c(Cl)nccn2n1

nearest known ligand 0.32

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ FLT3 P36888 1/20 0.32
▸ HTR6 P50406 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24659 0.83 — —
SCHEMBL15221252 0.81 PDE10A (0.38) FLT3HTR6
SCHEMBL19266 0.77 KDR (0.48) —
SCHEMBL20035 0.76 JAK2 (0.51) —
SCHEMBL20918 0.74 FLT1 (0.42) —
SCHEMBL15210382 0.74 JAK2 (0.53) —
SCHEMBL16394606 0.74 CDK19 (0.44) FLT3
SCHEMBL15221144 0.74 JAK2 (0.46) —
SCHEMBL21018 0.73 NFKB1 (0.51) —
SCHEMBL15221233 0.73 JAK2 (0.60) FLT3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2817310-B1 8-SUBSTITUTED 2-AMINO-[1,2,4]TRIAZOLO[1,5-A]PYRAZINES AS SYK TRYROSINE KINASE INHIBITORS AND GCN2 SERIN KINASE INHIBITORS MERCK PATENT GMBH (DE) 2018-03-21 — — EP disclosed
WO-2012025186-A1 TRIAZOLOPYRAZINE DERIVATIVES MERCK PATENT GMBH (DE) 2012-03-01 — — WO disclosed
Send feedback